Table 2.

DAS28-CRP intra- and interrater reliability.

VariablesIntrarater Reliability (PP)nInterrater Reliability (CC)
nSituation 1 ICC (95% CI)MDCnSituation 2 †† ICC (95% CI)MDCPt vs HCP1, ICC (95% CI)Pt vs HCP2, ICC (95% CI)HCP1 vs HCP2, ICC (95% CI)
Visit 1§, all (primary)1210.87 (0.80–0.91)1.121870.87 (0.83–0.90)1.13600.75 (0.61–0.84)0.79 (0.68–0.87)0.86 (0.78–0.91)
Visit 3§, all1210.93 (0.90–0.95)0.921870.92 (0.90–0.94)1.00460.86 (0.71–0.93)0.87 (0.75–0.93)0.90 (0.82–0.94)
Visit 3§, subgroup A670.94 (0.90–0.96)0.841020.93 (0.90–0.96)0.92250.87 (0.71–0.94)0.87 (0.72–0.94)0.90 (0.78–0.95)
Visit 3§, subgroup B540.92 (0.87–0.95)1.00850.91 (0.86–0.94)1.08210.81 (0.47–0.93)0.84 (0.63–0.93)0.87 (0.71–0.95)
Visit 1 pretraining, all1210.88 (0.84–0.92)1.041870.90 (0.87–0.92)0.99600.69 (0.51–0.84)0.74 (0.59–0.84)0.86 (0.78–0.91)
  • Situation 1: assessment of intrarater reliability in the PP population with short time followup performed within 1–3 days.

  • †† Situation 2: assessment of intrarater reliability in the PP population with short time followup performed within 1–7 days.

  • § For intrarater reliability, visit 1 is compared with visit 2, and visit 3 is compared with visit 4.

  • For intrarater reliability, visit 1 pretraining is compared to visit 1 post-training. DAS28-CRP: 28-joint count Disease Activity Score using C-reactive protein; ICC: intraclass correlation coefficient; MDC: minimal detectable change; PP: per-protocol population; CC: complete-case population; Pt: patient; HCP1: healthcare professional (experienced rheumatologist); HCP2: medical student trained in joint assessments.